Knight Therapeutics Inc. (FRA:04K)

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 121.55M CAD in the quarter ending September 30, 2025, with 31.74% growth. This brings the company's revenue in the last twelve months to 413.85M, up 18.70% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

• Revenue (ttm): 413.85M CAD
• Revenue Growth: +18.70%
• P/S Ratio: 1.41
• Revenue / Employee: 555.50K CAD
• Employees: 745
• Market Cap: 357.00M EUR

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	371.30M	43.11M	13.13%
Dec 31, 2023	328.20M	34.64M	11.80%
Dec 31, 2022	293.56M	50.09M	20.57%
Dec 31, 2021	243.48M	43.96M	22.03%
Dec 31, 2020	199.52M	152.06M	320.39%
Dec 31, 2019	47.46M	34.96M	279.69%
Dec 31, 2018	12.50M	3.87M	44.78%
Dec 31, 2017	8.63M	2.69M	45.35%
Dec 31, 2016	5.94M	4.90M	472.81%
Dec 31, 2015	1.04M	672.00K	184.11%
Dec 31, 2014	365.00K	-	-